Market Research Blog – Page 953 – New Product Development

Central Lab Market Expected to Reach USD 4,473.5 Million by 2033, Growing at a CAGR of 5.8%

The global central lab market is projected to experience substantial growth, with an estimated value of approximately USD 2,543.9 million in 2023. During the forecast period from 2023 to 2033, the market is anticipated to expand at a compound annual growth rate (CAGR) of 5.8%. By the end of this period, the total net worth of central labs worldwide could reach up to USD 4,473.5 million.

This growth is driven by the increasing demand for high-quality laboratory services, advancements in laboratory technologies, and the rising trend of outsourcing laboratory testing. As healthcare providers and pharmaceutical companies increasingly rely on central labs for accurate and efficient testing, the market is well-positioned for continued expansion.

The evolution of the central lab industry is expected to receive a substantial boost over the projected period due to the increasing number of clinical trials. The prevalence of genetic illnesses has set a significant trend, leading to a surge in demand for private layers involved in the central lab sector.

In recent years, pharmaceutical and biopharmaceutical firms have entirely outsourced their research and development activities to central labs operated by private players. Besides lowering expenses for pharmaceutical and biotechnology businesses, central labs guarantee that findings are supplied more quickly and accurately.

Key Takeaways from the Global Central Lab Industry Study Report by FMI

The United States is the leading region, with almost 51% share of the total demand for central lab services generated worldwide in 2022.
Germany is the leading country in Europe that garnered almost 25% share of the total demand for central lab services in Europe in 2022.
The demand for central labs in the United Kingdom is poised to register a higher CAGR of 5.1% in Europe from 2023 to 2033.
China is the leading market in Asia, with a projected CAGR of 7.6% for its clinical central laboratory market from 2023 to 2033.
India is likely to follow China in demand for clinical trials with an annual growth rate of 6% during the forecast years.

“Central labs are increasingly adopting cutting-edge technical solutions, which is helping the overall market to expand and is projected to continue. Correspondingly, the majority of central laboratories have fully automated their procedures, allowing them to save money and time,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).

Competitive Landscape for the Global Central Lab Industry Players

The overall market is fairly consolidated, as only some players successfully create a value chain by creating central labs at different locations. However, escalating government support in emerging economies following the pandemic is expected to encourage many new players to enter the market, intensifying competition.

Global Central Lab Industry Key Companies Profiled

Covance (Labcorp)
Eurofins Global Central Library
PPD Central Lab
ICON Central Labs
Medpace Reference Laboratory
Q² Solutions
ACM Global Laboratories
Labconnect Inc.
Cerba Research
Medicover Integrated Clinical Services
Versiti Inc.
A.P. Møller Holding A/S
Ampersand Capital Partners
Lambda Therapeutics Research Ltd
Cirion Biopharma Research Inc.

Recent Developments by the Global Central Lab Service Providers

LabConnect Incorporate announced the expansion of its facilities in Johnson City in September 2020 to increase the production of clinical trial kits. This expansion has been planned to support the company’s rapid growth in the fields of immuno-oncology research and cell and gene therapy. The corporation is also expanding the storage capacity of its biorepository for specimens by moving its headquarters to Tennessee.
Labcorp or Covance Inc., a preeminent global life sciences company, declared that it was expanding its CB trial laboratory in June 2022. Its central laboratory is shared by a top Japanese provider of clinical laboratory testing services named BML. The company decided to expand existing laboratory capabilities in Japan to strengthen its central laboratory presence and drug development.

Key Segments Profiled in the Global Central Lab Industry Survey

By Service Type:

Genetic Services
Biomarker Services
Microbiology Services
Special Chemistry Services
Other Service Types

By End User:

Pharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
The Middle East & Africa (MEA)

Author by:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Veterinary Electrosurgery Market Projected to Reach USD 995.2 Million by 2033, Growing at a CAGR of 6.7%

The global veterinary electrosurgery market is valued at approximately USD 520.32 million as of 2023 and is set for significant growth over the next decade. Projections indicate a robust average compound annual growth rate (CAGR) of 6.7% from 2023 to 2033, positioning the market to exceed USD 995.2 million by the end of the forecast period.

The growth of the veterinary electrosurgery market is driven by increasing awareness of advanced surgical techniques, rising demand for veterinary procedures, and the growing adoption of electrosurgical instruments in animal healthcare. As pet ownership continues to rise globally, veterinarians are increasingly turning to innovative electrosurgical solutions to enhance surgical precision and improve patient outcomes.

Furthermore, development in veterinary surgery has always followed in the footsteps of human surgery. Innovative techniques of surgeries to make them less painful is driving the growth of the market. In addition, the proliferation of government administrations associated with animal healthcare and even distinct animal healthcare organizations will surge the demand for treatments across developing nations. These organizations focus on animals in sanctuaries and zoos. This, in turn, will boost the market growth.

On the contrary, the time taken for approvals for medication and instruments required for surgeries is derailing the progress of the market. In addition, the constant emergence of newer ailments amongst animals is a continuous challenge faced by the Global Veterinary Electrosurgery Industry.

Key Takeaways from the Global Veterinary Electrosurgery Industry Study

Veterinary electrosurgery is expected to garner a market value of USD 993.41 Million by registering a CAGR of 7% in the forecast period 2022-2032.
By product, consumables and accessories segment is expected to register a CAGR of more than 15% for the veterinary electrosurgery market during the forecast period.
By animal, small animals are expected to possess a 65% market share for the veterinary electrosurgery market during the forecast period.
By end use, veterinary hospitals and clinics segment is expected to hold a market share of more than 80% in the forecast period 2022-2032.
By application, general surgery is expected to possess a market share of nearly 30% market share in 2022-2032.
U.S is projected to register a CAGR of 8% during the forecast period.
U.K. is anticipated to grow at 9% CAGR for veterinary electrosurgery.

Global Veterinary Electrosurgery Industry Competitive Landscape

Key players in the global veterinary electrosurgery include Symmetry Surgical Inc, CVS Group, KARL STORZ, Avante Animal Health, B. Braun Melsungen AG, Medtronic, Summit Hill Laboratories, Kwanza Veterinary, Burtons Medical Equipment Ltd, EICKEMEYER and Macan Manufacturing. Some of the recent developments in the global market are:

In June 2021, CVS Group announced the planning of a new state-of-the-art specialist veterinary hospital in Bristol. The hospital will open in 2022 with modern technology and treatments in all disciplines, including orthopedics, general surgery, internal medicine, neurology, and neurosurgery, among others.
Medtronic, a key player in the market is focusing on developing instruments that will be technologically advanced to fasten the process of general surgeries for animals.

More Valuable Insights Available

FMI, in its new offering, presents an unbiased analysis of the global market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by product (Bipolar Electrosurgery Instruments, Monopolar Electrosurgery Instruments, Consumables and accessories), Animal Type (Small Animal, Large Animal), Application (General Surgery, Dental Surgery, Gynecological and urological Surgery, Orthopedic Surgery, Others), End Use (Veterinary Hospitals and Clinics, Others) & Region Forecast till 2032

Global Veterinary Electrosurgery Industry Key Segments Covered

Global Veterinary Electrosurgery Industry by Product:

Bipolar Veterinary Electrosurgery Instruments
Monopolar Veterinary Electrosurgery Instruments
Veterinary Electrosurgery Consumables & Accessories

Global Veterinary Electrosurgery Industry by Animal Type:

Veterinary Electrosurgery for Small Animals
Veterinary Electrosurgery for Large Animals

Global Veterinary Electrosurgery Industry by Application:

General Veterinary Electrosurgery
Dental Veterinary Electrosurgery
Gynecological & Urological Veterinary Electrosurgery
Orthopedic Veterinary Electrosurgery
Other Veterinary Electrosurgery Applications

Global Veterinary Electrosurgery Industry by End Use:

Veterinary Electrosurgery across Veterinary Hospitals And Clinics
Veterinary Electrosurgery across Other End Users

Global Veterinary Electrosurgery Industry by Region:

North America Veterinary Electrosurgery Market
Latin America Veterinary Electrosurgery Market
Europe Veterinary Electrosurgery Market
Asia Pacific Veterinary Electrosurgery Market

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Oxygen Therapy Equipment Market Set to Reach USD 6.4 Billion by 2032, Growing at a 7.4% CAGR

The oxygen therapy equipment market is projected to experience robust growth over the next decade, with an anticipated compound annual growth rate (CAGR) of 7.4% during the period from 2022 to 2032. The market value is expected to increase from USD 3.1 billion in 2022 to USD 6.4 billion by 2032.

This growth is driven by the rising prevalence of respiratory diseases, an increasing geriatric population, and advancements in oxygen therapy technologies. As healthcare providers seek effective solutions to manage respiratory conditions, the demand for oxygen therapy equipment is expected to surge.

The rising popularity and adoption of on-demand and continuous Portable Oxygen Concentrators (POC) in diverse applications, especially in emergency medicine, are expected to fuel the demand in the forthcoming years. This surge can be attributed to global competitors entering the market, increasing consumer demand for portable technology, and the clinical urgency for greater mobility support for the geriatric population. The industry anticipates a significant boost due to continuous innovation, resulting in more efficient units and reduced prices.

Increasing incidences of chronic respiratory diseases coupled with rising demand for home healthcare are the major drivers of the market. This can be ascribed to the increasing geriatric population suffering from various kinds of chronic diseases in which oxygen therapy or oxygen support is required. Additionally, increasing levels of air pollution, and smoking habits of the population especially youth, among others have significantly contributed to an increase in the prevalence of respiratory diseases, thereby increasing the demand for oxygen therapy equipment.

As per the National Institutes of Health (NIH), nearly 12 million adults have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. and 120,000 people die each year. According to the data published by the Global Asthma Network (GAN), asthma affects nearly 334 million people worldwide.

North America dominates the oxygen therapy equipment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing awareness about the benefits associated with oxygen therapy in hospitals and an increasing number of end-users in this region.

Key Takeaways from the Oxygen Therapy Equipment Market Study

The global Oxygen Therapy Equipment Industry was valued at US$ 3.1 Million by the 2022-end
The US to account for the highest value share of US$ 2.4 Billion of global market demand for Oxygen Therapy Equipment Market in 2032
From 2015 to 2021, Oxygen Therapy Equipment demand expanded at a CAGR of 9.7%
By Product, the Oxygen Source Equipment category constitutes the bulk of the Oxygen Therapy Equipment Market with a CAGR of 8.2%.
By Portability, the Stationary Devices segment dominates the Oxygen Therapy Equipment Market with a CAGR of 7.8%.

“The rising popularity and adoption of on-demand and continuous Portable Oxygen Concentrators (POC) in a wide range of applications such as emergency medicine is also expected to fuel the demand over the forecast period,” remarks an FMI analyst.

Oxygen Therapy Equipment Market Competitive Landscape

Players in the Global Oxygen Therapy Equipment Industry focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In July 2021, Belluscura (BELL) had signed a third distribution deal and first agreement with a durable medical equipment provider, for its X-PLO2R portable oxygen concentrator portfolio. The durable medical equipment (“DME”) has multiple stores in several states and an online store. Meanwhile, the third distributor has issued its first purchase order with anticipated delivery of the X-PLO2R portable oxygen concentrator expected in less than ninety days.
In June 2020, Armstrong Medical introduced the second generation FD140i, an improved dual therapy flow driver with an easier transition from CPAP to HFOT.
In August 2019, OxyGo LLC announced the launch of their new six flow setting, Bluetooth enabled POC. At only 4.7 pounds, and with 6 flow settings, the OxyGo NEXT offers the highest oxygen output per pound of weight of any portable oxygen concentrators currently on the market. Created to meet the needs of oxygen therapy patients and home medical equipment providers – for use at home, away, and for travel. OxyGo NEXT will allow healthcare providers to improve patient outcomes through a new wireless connectivity platform using Bluetooth technology.
In October 2018, Resmed launched CPAP mask-Airlift f30i for Hospitals and Respiratory Care Physicians in the US.

Oxygen Therapy Equipment Market Key Companies Profiled:

Philips Healthcare
Linde Healthcare
Chart Industries, Inc.
Invacare Corporation
Becton, Dickinson and Company
Smiths Medical
Drägerwerk AG & Co. KGaA
Teleflex Incorporated
Fisher & Paykel Healthcare Corporation Limited
Taiyo Nippon Sanso Corporation, Inogen, Inc.
Heinen + Löwenstein GmbH & Co. KG
Others

A Full Report Overview

Key Segments Covered in the Oxygen Therapy Equipment Market Report

by Product:

Oxygen Source Equipment
Oxygen Therapy Equipment for Cardiovascular & Thoracic Surgeries
- Oxygen Concentrators
- Liquid Oxygen
- Oxygen Cylinders
Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannulas
- Venturi Masks
- Non-Rebreather Masks
- Bag-Valve Masks
- Other Oxygen Delivery Devices

by Portability:

Stationary Oxygen Therapy Equipment Devices
Portable Oxygen Therapy Equipment Devices

by Application:

Oxygen Therapy Equipment for COPD
Oxygen Therapy Equipment for Asthma
Oxygen Therapy Equipment for Cystic Fibrosis
Oxygen Therapy Equipment for Respiratory Distress Syndrome
Oxygen Therapy Equipment for Pneumonia
Oxygen Therapy Equipment for Other Diseases

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

High Flow Ventilators Market Projected to Reach USD 67.6 Billion by 2032, Growing at a 10% CAGR

The High Flow Ventilators Market is poised for remarkable growth, with an expected valuation of USD 25 billion in 2021 and USD 27 billion in 2022. By 2032, the market is projected to surge to USD 67.6 billion, reflecting a compound annual growth rate (CAGR) of 10% throughout the forecast period.

This significant increase in market value underscores the rising demand for high flow ventilators, driven by advancements in respiratory care technologies and an increasing prevalence of respiratory diseases. High flow ventilators are critical in providing enhanced support to patients with severe respiratory conditions, making them an essential component of modern healthcare systems.

Ventilators are critical life-support devices that provide patients with respiratory therapy. High-flow ventilators are a form of respiratory support device that uses a nasal cannula to provide a high-flow oxygen blend, making them ideal for severe respiratory disorders. High-flow ventilators are also commonly used to treat hypoxemic respiratory failure. During the projection period, the high prevalence of COPD cases is expected to drive the market’s rapid rise.

The increased frequency of respiratory illnesses, particularly COPD cases, and the growing worldwide elderly population will have a substantial impact on the Global High Flow Ventilators Industry between 2022 and 2032. In response to the increasing number of surgeries, demand for inexpensive and high-end critical care technology is likely to fuel market expansion. The importance of hospitals and medical emergency services adds to the demand for High-Flow Ventilators.

The market for High-Flow Ventilators is driven by a variety of end-use segments, including hospitals, ambulatory surgical centers, specialized clinics, long-term care facilities, and others. Hospitals are likely to be the most important contributors to the growth of the Global High Flow Ventilators Industry during the forecast period.

“High prevalence of COPD cases, as well as other respiratory conditions, will likely propel the global growth of the Global High Flow Ventilators Industry over the forecast period,” says an FMI analyst.

High Flow Ventilators Market Key Takeaways:

Budget constraints and stringent regulations may hinder the market growth of high-flow ventilators.
The market for high-flow ventilators will benefit from increased demand for inexpensive and innovative technologies in critical care.
North America held the biggest market share in 2018 and is expected to maintain this trend over the forecast period.
Due to an increase in respiratory diseases and expanding medical tourism, Asia Pacific is expected to emerge as a profitable market for high-flow ventilators.

High Flow Ventilators Market Competitive Landscape

ResMed, Hamilton Medical, HERSILL, S.L., Tecno-Gaz S.p.A., and Essex Industries, Inc., among others, are some of the major players in the Global High Flow Ventilators Industry profiled in the full version of the report.

Leading market players are focusing on dynamic business strategies to strengthen their market position. These businesses are adopting both organic and inorganic tactics like collaborations and partnerships to expand their product portfolio. Market players are keen on integrating advanced technologies into their products to ensure rapid growth.

High Flow Ventilators Market: Segmentation

The Global High Flow Ventilators Industry is segmented by modality type, end user, and region:

Based on Modality Type,

Portable High Flow Ventilators
Trolley Mounted High Flow Ventilators

Based on End Users,

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Long-Term Care Centers
Others

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Articulating Paper Forceps Market to Reach USD 2,156.8 Million by 2034, at a 4.5% of CAGR

The global articulating paper forceps market is projected to experience significant growth over the next decade, with revenues expected to rise from USD 1,388.8 million in 2024 to USD 2,156.8 million by 2034. According to market predictions, the industry is anticipated to grow at a compound annual growth rate (CAGR) of 4.5% during the forecast period. In 2023, the market recorded revenues of USD 1,135.4 million.

One of the key drivers of this growth is the increasing adoption of minimally invasive surgical techniques, such as laparoscopic and endoscopic procedures. Articulating paper forceps are crucial instruments in these procedures, offering superior precision, control, and dexterity. As the demand for minimally invasive surgeries continues to rise, the market for these specialized tools is expected to expand accordingly.

Manufacturers are responding to this demand by producing more advanced articulating paper forceps designed for enhanced performance. These innovations include ergonomic grips, improved jaw designs, and the integration of digital technologies, all of which contribute to greater precision and control during surgery.

The demand for articulating paper forceps is accelerating across the dental industry since more and more surgeons across the globe are using the same because of their improved maneuverability and flexibility. This assists the surgeons to function better and fast without any sort of hurdle or complications. This factor is considered one of the prominent reasons for the growth of the global articulating paper forceps market.

Articulating paper forceps are also termed articulating paper holders. In addition, they are typically utilized for holding articulation paper while simultaneously applying it to the patient orally. The articulation paper is applied with the help of a tweezers-like design with two conjoined blades with serrated tips at the working end.

The dental community habitually utilized articulating paper in order to identify contact points amongst the mandibular and maxillary teeth during all types of dental prosthesis insertions and natural tooth correction or any kind of adjustments. These corrections are done by particularly grinding the paper marks to achieve occlusal stability. Moreover, the articulating paper forceps hold the articulating paper when the dentists check for occlusion of dental restorations and teeth. When the articulating paper is held by the forceps instead of fingers, it ensures improved grip and complete coverage of the teeth restoration.

Key Takeaways

The global articulating paper forceps market is predicted to be driven by numerous factors including the increasing prevalence of dental procedures and escalating adoption of articulating paper forceps during dental procedures. The additional access to dental and medical care is enabling technological advancements and additionally increasing the practicing scope. Accelerating the occurrence of periodic disorders and technological advancements is likely to further promote the growth of articulating paper forceps market. Moreover, there is an enormous increase in the geriatric population across the world, and this boosts the market further.
According to the Patient Protection and Affordable Care Act (ACA), the awareness about dental health and the addition of various provisions have resulted in enhancing patients’ oral health. At a global level, there is more awareness among surgeons and patients to reduce the rates of infections, and this factor is increasing the sales of articulating paper forceps and, eventually, the global market of the same.
Similarly, with the global expansion of social and digital media along with awareness amongst consumers, they are rapidly becoming more selective about the treatments, which has elevated the efficiency of treating occlusal interferences and assists in adjusting the same. Tooth restorations and crown fillings are done at an alarming rate which has to be checked, and this is done with the help of articulated forceps.
The articulated paper forceps come in two types: straight articulating paper forceps and curved articulating paper forceps. The straight ones consist of tweezer-like jaws which are opened from 0 to 180 degrees angle, and this enables the instrument’s tip to maneuver in any direction. When there is a plane surface where an articulated movement within the tough spaces is not needed, straight articulating paper forceps are used, for instance, while performing bronchoscopies.

Competitive Landscape

Some of the key players in the global articulating paper forceps market are focusing on supplying delivery of dental equipment, software, and technology solutions to their clients. Such companies offer a broad range of products at exceptional value along with strong service and support.

Dental forceps for articulating paper are a type of dental instrument used to hold articulating paper in place during dental procedures. Articulating paper is a thin paper that is coated with ink and used to check the bite and occlusion of the teeth.

Key companies profiled:

New Surgical Instruments Co,
Ethicon US, LLC.
Richard Wolf GmbH,
Dental Health Products, Inc.,
SMILE SURGICAL IRELAND LIMITED,
Atlanta Dental,
Henry Schein, Inc.

More Insights into the Articulating Paper Forceps Market

North America is expected to dominate the global articulating paper forceps market over the forecast period. The growth of the North American region is attributed to the strict regulations pertaining to patient safety and the favorable regulatory environment which promotes investment in healthcare facilities.

Segments covered by:

Product Type,
End User,
Region

Author By:

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Elastography Imaging Market to Reach USD 10,426.4 Million by 2034, Growing at a 10.5% CAGR, Driven by Technological Advancements

The global elastography imaging market is projected to witness substantial growth over the next decade, according to new research from Future Market Insights. The market is expected to increase in value from USD 3,841.6 million in 2024 to USD 10,426.4 million by 2034, reflecting a robust compound annual growth rate (CAGR) of 10.5% over the forecast period.

A key driver of this growth is the integration of cutting-edge technologies, such as artificial intelligence (AI), into elastography imaging equipment. These advancements enable real-time monitoring and improve early disease detection by identifying cell swelling and tumor stiffness more efficiently. As the demand for early diagnosis continues to rise, sales of elastography imaging equipment are expected to grow at an impressive rate throughout the forecast period.

The increased focus on early detection and precise diagnostics is transforming the elastography imaging landscape, offering significant opportunities for manufacturers to innovate and meet the growing demand for advanced healthcare solutions.

The Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Elastography Imaging Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

The team of analysts at Future Market Insights are focussing on research and market study to produce different Elastography Imaging Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Elastography Imaging Market.

Elastography Imaging Market Key Players:

The writer will create content on the general strategies of market players. And then will write the key players in the market are: GE healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hitachi Ltd., Mindray Medical International Limited, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Landwind Medical, Esaote SpA, SonoScape Medical Corp, SuperSonic Imagine and others

Elastography Imaging Market Segmentation:

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

A Full Report Overview

Based on technique,

Ultrasound Elastography Imaging
1D transient Elastography
Point shear-wave Elastography
Shear-wave Elastography
MR based Elastography

Based on the application,

Gynecology & Obstetric
Cardiology
Orthopedic & Musculoskeletal
Vascular
Neurology
General Imaging

Based on modality,

Portable
On-Platform

Based on end-user,

Hospitals
Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers

Product Segmentation:

The investigation offers a top-to-bottom evaluation of different clients’ journeys pertinent to the market and its segments. The study endeavors to assess the current and future development possibilities, undiscovered roads, and factors that shape their income potential in the global market by breaking it into di such as its types, applications, and region-wise assessment.

Full in-depth analysis of the parent market:

The analysts at FMI are dedicated to providing insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.

Important changes in market dynamics:

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Author By:

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Medical Device Analytical Testing Outsourcing Market to Reach USD 10.8 Billion by 2034, Growing at 6.4% CAGR

The global medical device analytical testing outsourcing market is set to experience significant growth over the next decade, with industry value projected to rise from USD 5.844 Million in 2024 to USD 10,867.3 Million by 2034, according to a new report by Future Market Insights. This marks an impressive compound annual growth rate (CAGR) of 6.4% during the forecast period. The industry’s valuation at the end of 2023 was USD 5,492.40 million.

Key factors driving the market’s expansion include the scalability and flexibility that outsourcing provides. By outsourcing analytical testing, companies can efficiently scale their testing capabilities to match demand fluctuations, eliminating the need for fixed infrastructure investments. This flexibility is critical as businesses navigate varying testing needs across different phases of product development and market introduction.

Outsourcing partners also offer customized testing solutions that are tailored to meet client-specific requirements, ensuring optimal resource allocation and cost effectiveness. This allows companies to concentrate on their core competencies while leveraging the specialized expertise of outsourcing firms, ultimately enhancing operational agility and boosting competitiveness in the medical device sector.

The growing global prevalence of chronic diseases is driving up demand for medical device analytical testing outsourcing. The government’s increasingly stringent quality certificate rules are propelling the global medical device analytical testing outsourcing market forward. Class II devices require premarket approvals and 510 (k) clearance; however, obtaining such clearance is a time-consuming process; thus, such emerging scenarios have fuelled the growth of the global medical device analytical testing outsourcing market. Medical device manufacturers are hiring consultants to help them understand the documentation and regulations required for pre-market approvals.

The development of advanced devices such as surgical microscopes, surgical robots, neurosurgery devices, ophthalmic surgical devices, and many others has reduced the direct contact of humans in the surgical procedure, making quality certificates for medical devices mandatory. The growing demand for minimally invasive surgeries is driving the global medical device analytical testing outsourcing market forward. However, manufacturers are turning to medical device analytical testing outsourcing to ensure accuracy, precision, quality control, and periodic maintenance.

Medical Device Analytical Testing Outsourcing Market Key Takeaways

The global Medical Device Analytical Testing Outsourcing market is estimated at US$ 10.96 Billion during the forecast period.
The global Medical Device Analytical Testing Outsourcing market is estimated at US$ 5.11 Billion in 2021.
The U.S is projected to lead the market while procuring US$ 1.5 Billion while expanding at a CAGR of 7% during the forecast period.
China is anticipated to grow at 5.5% CAGR
The hospitals segment is predicted to lead the market with a CAGR of 6.15% during the assessment period.

“Because of improved healthcare infrastructure and government initiatives, Asia Pacific has the largest share of the global medical device analytical testing outsourcing market. Furthermore, rapid economic development in countries such as China and India are expected to significantly boost regional market growth over the forecast period.” Says an analyst at FMI.

Medical Device Analytical Testing Outsourcing Market Competitive Landscape

The global medical device analytical testing outsourcing market is highly fragmented. Mergers, acquisitions, and partnerships, among other strategies, were used by industry participants to maintain market share. The key market players are:

SGS
Toxikon, Inc
Eurofins Scientific
Pace Analytical Services LLC
Intertek Group plc
Wuxi AppTec
North American Science Associates, Inc.
Envigo
Charles River Laboratories International, Inc.
Medical Device Testing Services

Some of the recent developments in the global medical device analytical testing outsourcing market are:

In May 2022, Intertek renewed its contract with the Philippines Bureau of Customs for its Bulk and Break Bulk Cargo Clearance Enhancement Programme.
In May 2022, Intertek announced the launch of ‘Intertek Hydrogen’ which assists the hydrogen industry in commercializing ground-breaking technology securely into the future.

Medical Device Analytical Testing Outsourcing Industry Report Segmentation:

By Service:

Extractable and Leachable
Material Characterization
Physical Testing
Bioburden Testing
Sterility Testing
Other Tests

By Device Type:

Reprocessed Devices
Others Medical

By End Use:

Hospitals
Others

By Therapeutic Areas:

Cardiology
Diagnostic Imaging
Orthopedic
IVD
Ophthalmic
General & Plastic Surgery
Drug Delivery
Endoscopy
Dental
Diabetes Care
Others

Author By:

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Patient Portal Market Set to Reach USD 19.08 Billion by 2034 at a 14.8% of CAGR

The global patient portal market is projected to reach USD 4,800.3 million by 2024 and is expected to experience robust growth, with a compound annual growth rate (CAGR) of 14.8% through 2034. By the end of the forecast period, the market is anticipated to reach USD 19.08 billion, reflecting the increasing adoption of digital health solutions and a strong emphasis on patient-centered care.

The surge in demand for efficient healthcare management systems has significantly contributed to the growth of the patient portal market. The rising implementation of electronic health records (EHRs) by healthcare providers has streamlined administrative processes, improving overall efficiency. Additionally, these digital tools play a crucial role in enhancing patient engagement and satisfaction, providing easy access to health information and empowering patients to take an active role in their healthcare journey.

The growth of healthcare facilities worldwide influences the Global Patient Portal Industry. Patient portal usage is rising quickly due to mandatory federal regulations and the integration of growth in the US electronic health records (EHR) market. Additionally, technology-based businesses are creating web-based apps for patient portals. This provides access to store and retrieve crucial data as a result. The COVID-19 pandemic has fueled a rise in teleconsultation services.

Patient portals are secure online platforms that give patients easy access to their medical information, appointment scheduling, and communication with their healthcare providers. They offer a variety of features, including:

Access to medical records, such as lab results, imaging reports, and medication lists
Appointment scheduling and reminders
Prescription refills
Secure messaging with healthcare providers
Online bill pay
Educational resources on health and wellness

Patient portals offer several benefits for both patients and healthcare providers. For patients, they can provide convenience, empowerment, and peace of mind. For healthcare providers, they can improve efficiency, communication, and patient engagement.

The increasing adoption of patient portals is being driven by some factors, including:

The rising demand for EHRs: EHRs are electronic versions of patients’ medical records. They provide a central repository for all of a patient’s medical information, which can be accessed by healthcare providers from different locations. Patient portals are often integrated with EHR systems, which makes it easy for patients to access their medical information through the portal.
Mandatory federal norms: The Meaningful Use program incentivized healthcare providers to adopt EHRs and patient portals in the United States. While the Meaningful Use program ended in 2018, many incentives are still in place through other programs, such as the Merit-based Incentive Payment System (MIPS).
The benefits of patient portals: Patient portals offer several benefits for both patients and healthcare providers, as mentioned above. This is leading to increased adoption of patient portals by healthcare facilities of all sizes.

Patient Portal Market Key Takeaways:

Patient portals are secure online platforms that give patients easy access to medical information, appointment scheduling, and communication with their healthcare providers.
The increasing adoption of patient portals is attributed to their benefits to patients and healthcare providers.
Patient portals can help patients manage their health better, improve communication with their healthcare providers, and reduce healthcare costs.
Healthcare providers can use patient portals to improve patient care, increase efficiency, and reduce costs.
The critical drivers of the Global Patient Portal Industry include the increasing adoption of EHRs, the growing demand for teleconsultation services, and government support for digital healthcare initiatives.

Patient Portal Market Key Companies Profiled:

Allscripts Healthcare Solutions, Inc.
NextGen Healthcare Information Systems
McKesson Corporation
Cerner Corporation
Greenway Health, LLC
athenahealth, Inc.
Epic Systems Corporation
GE Healthcare
Medfusion Inc.

A Full Report Overview

Key Segments Covered in the Patient Portal Market

By Type:

Standalone Patient Portal
Integrated Patient Portal

By Delivery Mode:

Web-based Patient Portal
Cloud-based Patient Portal

By End-Use:

Patient Portal for Providers
Patient Portal for Payers
Others

By Region:

North American Patient Portal Market
Latin America Patient Portal Market
Europe Patient Portal Market
Asia Pacific Patient Portal Market
Middle East & Africa Patient Portal Market

Author By:

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Back Therapy Kit Market to Reach USD 6.1 Billion by 2034 at a 4.2% of CAGR

The global back therapy kit market is projected to grow significantly over the next decade, reaching a value of USD 6.1 billion by 2034, up from its current valuation of USD 4 billion in 2024. Leading the product category, the battery-operated segment currently holds over 81.5% of the market share and is expected to grow at a compound annual growth rate (CAGR) of 4.2% during the forecast period.

The rapid growth of technological infrastructure is playing a pivotal role in boosting the sales of back therapy kits. Manufacturers are increasingly integrating advanced features and cutting-edge technology into traditional kits, resulting in more efficient equipment and a superior consumer experience.

As demand for effective back therapy solutions continues to rise, the integration of these innovations will further enhance the market’s growth prospects, offering consumers more personalized and efficient options for back pain management.

Battery-powered back therapy kits are leading the market, capturing over 81.5% of the market share in 2022. This dominance highlights the preference for portable and convenient solutions for back pain management.

Back Therapy Kits come across as at-home medical devices used for managing pain, especially in the lower back. At the lower back, they are secured with a strap. The Back Therapy Kits make use of TENS technology to transmit vibration to the body to relieve pain.

Patients suffering from back pain are advised to attend 15 to 20 sessions every single day using Back Therapy Kits. The sportspersons prefer them for relaxing their lower back.

These days, strapless Back Therapy Kits are the buzzword. Homecare settings followed by rehabilitation centers generally use Back Therapy Kits.

At the same time, higher costs involved concerning Back Therapy Kits are expected to restrain the Back Therapy Kits market going forward.

In its latest market study entitled ‘Back Therapy Kits Market’, Future Market Insights has entailed these facts with future prospects. It has its line of expertise in the form of analysts and consultants to deploy an eagle’s eye view in its primary, secondary, and tertiary modes of research.

“With realization of the fact that vibration provided by Back Therapy Kits provides relief from muscle strain, the global Back Therapy Kits market is expected to go good in the forecast period”, says an analyst from Future Market Insights.

Key Takeaways from Back Therapy Kits Market

North America holds the largest market share with the US witnessing continuous development of therapies.
Europe is expected to stand second with the UK and Germany showing the same prospects as the US.
The Asia-Pacific is expected to grow at the quickest rate in the Back Therapy Kits market in the forecast period with increasing incidences of lower back pain all across Japan, China, and India. Also, the WHO has confirmed that every sixth person in India suffers from arthritis at a certain point in their lives. The rising geriatric population is another point to look into. This is evident from the fact that as per the UN’s ESCAP (Economic and Social Commission for Asia and the Pacific), nearly 1.3 Billion people will be aged 60 and above by the year 2050.

Back Therapy Kits Market Competitive Landscape:

The key players in Back Therapy Kits market include Sanofi S.A., Polar Products Inc., Hocomo, Bayer AG, Brooks Life Sciences, Tynor, Amedica, Alliance Spine, Globus Medical, Captiva Spine, and likewise.
The players mentioned above are engaging in various modes of expansion like new product launches, mergers, acquisitions, partnerships, and joint ventures, and likewise to make a mark for themselves amidst the call for innovations.
Pfizer, Inc. is known for its drug called ‘tanezumab’ since the year 2017. It was when it received approval from the US FDA with regards to treating chronic low back pain. It’s interesting to learn that tanezumab is one of the humanized monoclonal immunoglobulin G2 (IgG2) to substitute opioids.

Key Segments Covered in the Back Therapy Kits Market Study

Back Therapy Kits Market by Product Type:

Strapped Back Therapy Kits
Strapless Back Therapy Kits

Back Therapy Kits Market by Connectivity:

Wired Back Therapy Kits
Battery-Operated Back Therapy Kits

Back Therapy Kits Market by End User:

Back Therapy Kits for Hospitals
Back Therapy Kits for Orthopedic Clinics
Back Therapy Kits for Rehabilitation Centers
Back Therapy Kits for Long-term Care Centers
Back Therapy Kits for Homecare Settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Neurovascular Device Market to Reach USD 3.9 Billion by 2034 at a 2.7% of CAGR

The global neurovascular device market is projected to reach a value of USD 3.0 billion by 2024. The market is set to continue on an upward trajectory, with growth projected to achieve a market value of USD 3.9 billion by 2034, reflecting a moderate compound annual growth rate (CAGR) of 2.7% throughout the forecast period.

As the demand for neurovascular devices continues to grow due to advancements in medical technology and the increasing prevalence of neurological conditions, the market is expected to expand steadily. This sustained growth offers opportunities for further innovations and enhanced solutions in the field of neurovascular care.

One of the key drivers of this market’s growth is the increasing incidence of neurological disorders, particularly strokes. Strokes are a leading cause of death and disability worldwide, prompting healthcare providers to adopt advanced neurovascular devices for better patient outcomes. The shift from traditional open surgeries to minimally invasive procedures has not only improved patient comfort but has also reduced healthcare costs.

In recent years, technological advancements have led to the development of cutting-edge neurovascular devices. These devices include stent retrievers, embolization coils, flow diverters, and liquid embolic agents, among others. The continuous innovation in materials and design has enhanced the efficacy of these devices, making them safer and more efficient for neuro-interventional procedures.

Furthermore, the growing aging population has contributed to the expansion of the Global Neurovascular Devices Industry. With an aging demographic, there is an increased susceptibility to neurovascular diseases, necessitating a higher neurovascular guidewires market demand for these devices. Additionally, the expanding awareness of these conditions and the availability of advanced treatment options have spurred market growth.

Key Neurovascular Devices Used In Interventional Neurology Include:

Stent Devices: Stents are used to treat intracranial stenosis, which involves the narrowing of blood vessels in the brain. These devices are designed to improve blood flow and prevent strokes. They can be self-expanding or balloon-expandable.
Coil Devices: Coils are used to treat intracranial aneurysms. They are inserted into the aneurysm to induce clotting, thereby preventing the risk of rupture. Coiling is a less invasive alternative to surgical clipping.
Embolization Devices: These devices block or divert blood flow in AVMs or other vascular abnormalities. They include detachable balloons and various embolic agents.
Thrombectomy Devices: Thrombectomy devices are used to remove blood clots from the brain’s blood vessels, primarily in the treatment of acute ischemic strokes. These devices are highly time-sensitive, as quick intervention is crucial in stroke cases.
Flow Diverters: Flow diverters are used to treat wide-necked aneurysms by diverting blood flow away from the aneurysm sac. They are relatively newer devices in the neurovascular field.
Microcatheters: Microcatheters are thin, flexible catheters used to navigate the intricate blood vessels of the brain. They are crucial for precise device placement during neuro-interventional procedures.
Guidewires: Neurovascular guidewires act as the compass for traversing the intricate pathways of the neurovasculature, providing a vital roadmap for the precise deployment of accompanying medical instruments.

The market for neurovascular devices in interventional neurology has been growing steadily due to several factors, including an aging population, increased awareness of neurovascular diseases, and advancements in technology and minimally invasive procedures. Additionally, research and development efforts continue to focus on improving the safety and efficacy of these devices.

Neurovascular Devices Market: A Look at Recent Developments:

In 2020, Johnson & Johnson introduced a groundbreaking innovation in stroke solutions with the launch of Cerenovus stroke solutions. This revolutionary product is designed to effectively address clot-related issues. At the heart of this cutting-edge solution lies the Big Bore Catheter, paired with the Emo Trap 3 revascularization device.
In a strategic move to expand its presence in the global neurovascular market, Penumbra forged a strategic partnership with Genesis MedTech in 2021. This dynamic collaboration aims to elevate the market’s stature and impact in China, showcasing a commitment to advancing neurovascular healthcare in the region.
In a parallel development, Pehnox, a prominent player in the neurovascular industry, ventured into the European market by establishing a new entity in the United Kingdom. This bold move underscores Pehnox’s dedication to enhancing the neurovascular market size across Europe, signaling a new era of neurovascular healthcare solutions for the continent.

Neurovascular Devices Market Key Competitor Companies:

Johnson & Johnson
Medtronic PLC
Stryker Corporation
Terumo Corporation
Penumbra

Neurovascular Devices Market: Segmentation

By Product:

Aneurysm Coiling and Embolization Devices
Cerebral Balloon Angioplasty
Stenting Systems
Support Devices
Neurothrombectomy Devices

By Disease Pathology:

Ischemic Strokes
Cerebral Aneurysm
Carotid Artery Stenosis
Arteriovenous Malformations
Fistulas
Others

By End User:

Hospitals and Surgical Centers
Ambulatory Care Centers
Research Laboratories
Academic Institutes

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: